🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1/2, open-label, multicenter study to determine the efficac...
Status
Active Not Recruiting
Location
Local Institution - 0006
Start Date
2017-11-27
Trial ID
NCT03331198
The purpose of this study is to evaluate the safety, efficacy, and PK of Vi...
Status
Recruiting
Location
Arkansas Childrens Hospital
Start Date
2022-10-12
Trial ID
NCT05491525
Treatments Being Tested
This is a research study to understand and determine the effectiveness of e...
Status
Completed
Location
NYU Langone Health
Start Date
2021-06-17
Trial ID
NCT04218708
The immune system may be involved in the recognition and destruction of tum...
Status
Recruiting
Location
University Hospital of Besançon
Start Date
2025-02-10
Trial ID
NCT06626269
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy of ixekizumab do...
Status
Completed
Location
Total Skin and Beauty Dermatology Center PC
Start Date
2015-08
Trial ID
NCT02513550
Treatments Being Tested
The MRI scan is one of the most important tools for diagnosing multiple scl...
Status
Completed
Location
Zuyderland MC
Start Date
2023-09-12
Trial ID
NCT05718947
Treatments Being Tested
This phase II trial studies the effects of luspatercept with or without hyd...
Status
Terminated
Location
Mayo Clinic Hospital in Arizona
Start Date
2023-02-20
Trial ID
NCT05005182
Self-injurious thoughts and behaviors (SITBs) are a serious public health c...
Status
Withdrawn
Location
Catholic University
Start Date
2024-02-01
Trial ID
NCT05583279
Treatments Being Tested
Determine the effect on weight loss and obesity-related comorbidities in pa...
Status
Unknown
Location
Ibrahim Bin Hamad Obaidullah Hospital
Start Date
2023-01-16
Trial ID
NCT05705388
Treatments Being Tested
Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer...
Status
Not Yet Recruiting
Location
London Health Sciences Center
Start Date
2026-02
Trial ID
NCT07292142
Treatments Being Tested